March 24, 2017 Biomarkers for cardiovascular risk in patients with diabetes. Heart. 2016;102:1939-1941
March 24, 2017 Trends in the epidemiology of cardiovascular disease in the UK. Heart. 2016;102:1945-1952
Bhatnagar P, Wickramasinghe K, Wilkins E, Townsend N
March 24, 2017 Cardiovascular risk assessment and treatment in chronic inflammatory disorders in primary care. Heart. 2016;102:1957-1962
Emanuel G, Charlton J, Ashworth M, Gulliford MC, Dregan A
March 23, 2017 Association between prediabetes and risk of cardiovascular disease and all cause mortality: systematic review and meta-analysis. BMJ. 2016;355:i5953
Huang Y, Cai X, Mai W, Li M, Hu Y
Keep up with all the latest from the cardiometabolic world. For breaking news, website updates and exclusive invitations to events with your peers.
Expert Opinions What are the key ingredients to achieve changes in sedentary behaviours at the societal level?
Lise Gauvin, PhD, Professor, Department of Social and Preventive Medicine, Université de Montréal; Associate Scientific Director for Population Health Research, CHUM Research Centre, Montréal, QC, Canada
Expert Opinions Why is poor cardiorespiratory fitness such a powerful predictor of various clinical outcomes?
Jonathan Myers, PhD, FACC, FACSM, FAACVPR, FAHA, Health Research Scientist, VA Palo Alto Health Care System; Clinical Professor of Medicine, Stanford University, Palo Alto, CA, USA
Expert Opinions Are excess visceral adipose tissue, liver fat, ectopic fat deposition also observed even in adolescents?
Jonathan McGavock, PhD, Associate Professor, Department of Pediatrics and Child Health, Faculty of Medicine, Manitoba Institute of Child Health, University of Manitoba; CIHR Applied Public Health Chair in Resilience and Childhood Obesity, Winnipeg, MB, CA
In the Spotlight
Expert Opinions Is there a link between the socioeconomic status and the development of type 2 diabetes?
Gillian Booth, MD, MSc, FRCPC, Associate Professor, Department of Medicine, University of Toronto; Adjunct Scientist, Institute for Clinical Evaluative Sciences, Toronto, ON, Canada
Luc Van Gaal, MD, PhD, Professor of Medicine, Antwerp University Hospital, Faculty of Medicine, Department of Diabetology, Metabolism & Clinical Nutrition, Antwerp, Belgium
The International Chair on Cardiometabolic Risk